Current:Home > InvestMany cancer drugs remain unproven years after FDA's accelerated approval, study finds -Streamline Finance
Many cancer drugs remain unproven years after FDA's accelerated approval, study finds
View
Date:2025-04-13 11:42:55
The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients' lives?
In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years.
"Five years after the initial accelerated approval, you should have a definitive answer," said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. "Thousands of people are getting those drugs. That seems a mistake if we don't know whether they work or not."
The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs.
It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce better evidence before gaining full approval.
Patients get access to drugs earlier, but the tradeoff means some of the medications don't pan out. It's up to the FDA or the drugmaker to withdraw disappointing drugs, and sometimes the FDA has decided that less definitive evidence is good enough for a full approval.
The new study found that between 2013 and 2017, there were 46 cancer drugs granted accelerated approval. Of those, 63% were converted to regular approval even though only 43% demonstrated a clinical benefit in confirmatory trials.
The research was published in the Journal of the American Medical Association and discussed at the American Association for Cancer Research annual meeting in San Diego on Sunday.
It's unclear how much cancer patients understand about drugs with accelerated approval, said study co-author Dr. Edward Cliff of Harvard Medical School.
"We raise the question: Is that uncertainty being conveyed to patients?" Cliff said.Drugs that got accelerated approval may be the only option for patients with rare or advanced cancers, said Dr. Jennifer Litton of MD Anderson Cancer Center in Houston, who was not involved in the study.
It's important for doctors to carefully explain the evidence, Litton said.
"It might be shrinking of tumor. It might be how long the tumor stays stable," Litton said. "You can provide the data you have, but you shouldn't overpromise."
Congress recently updated the program, giving the FDA more authority and streamlining the process for withdrawing drugs when companies don't meet their commitments.
The changes allow the agency "to withdraw approval for a drug approved under accelerated approval, when appropriate, more quickly," FDA spokesperson Cherie Duvall-Jones wrote in an email. The FDA can now require that a confirmatory trial be underway when it grants preliminary approval, which speeds up the process of verifying whether a drug works, she said.
- In:
- Cancer
- FDA
veryGood! (894)
Related
- House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
- Russia begins nuclear drills in an apparent warning to West over Ukraine
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Chow Down
- Analysis: Iran’s nuclear policy of pressure and talks likely to go on even after president’s death
- NHL in ASL returns, delivering American Sign Language analysis for Deaf community at Winter Classic
- A woman has died in a storm in Serbia after a tree fell on her car
- Adele, Jay-Z, Dr. Dre, Fleetwood Mac: Latest artists on Apple Music's 100 Best Albums
- German author Jenny Erpenbeck wins International Booker Prize for tale of tangled love affair
- A steeplechase record at the 2024 Paris Olympics. Then a proposal. (He said yes.)
- How 2 debunked accounts of sexual violence on Oct. 7 fueled a global dispute over Israel-Hamas war
Ranking
- Skins Game to make return to Thanksgiving week with a modern look
- Ex-Washington state police officer acquitted in Black man’s death files claims alleging defamation
- Alaska man killed in moose attack was trying to take photos of newborn calves, troopers say
- Americans in alleged Congo coup plot formed an unlikely band
- Behind on your annual reading goal? Books under 200 pages to read before 2024 ends
- Stenhouse fined $75,000 by NASCAR, Busch avoids penalty for post All-Star race fight
- What’s in a name? A Trump embraces ex-president’s approach in helping lead Republican Party
- Louisiana Republicans reject Jewish advocates’ pleas to bar nitrogen gas as an execution method
Recommendation
Audit: California risked millions in homelessness funds due to poor anti-fraud protections
Will America lose Red Lobster? Changing times bring sea change to menu, history, outlook
A top ally of Pakistan’s imprisoned former premier Imran Khan is released on bail in graft case
Tornadoes wreak havoc in Iowa, killing multiple people and leveling buildings: See photos
How effective is the Hyundai, Kia anti-theft software? New study offers insights.
Mariachis. A flame-swallower. Mexico’s disputes between street performers just reached a new high
Surprise attack by grizzly leads to closure of a Grand Teton National Park mountain
Poland arrests sabotage suspects and warns of potential hostile acts by Russia